Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3021 Alone and in Combination With Nivolumab In Patients With Advanced Solid Tumors
NCT Number:
NCT03504488
Phase:
I/II
Protocol Type:
Treatment
Age Group:
Adult
Disease Sites:
Lung
Study Objectives:
The objective of this study is to assess safety and efficacy of CAB-ROR2-ADC in solid tumors
For more information about the trial above please contact the study team:
Trial opened at the following institutions: Medical University of South Carolina
Study Documents
(MUSC NetID required for document access)